PreveCeutical Medical (18H0) Financial Statements
0 Followers
PreveCeutical Medical Financial Overview
PreveCeutical Medical's market cap is currently C$8.13M. The company's EPS TTM is C$-0.00; its P/E ratio is -20.83; PreveCeutical Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Mar 24 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -14.43K | C$ -10.10K | C$ -9.86K | C$ -9.89K | C$ -5.09K |
| Operating Income | C$ -3.37M | C$ -812.47K | C$ -963.12K | C$ -1.10M | C$ -897.85K |
| EBITDA | C$ -1.35M | C$ -837.46K | C$ -955.09K | C$ -1.23M | C$ -829.83K |
| Net Income | C$ -1.58M | C$ -1.17K | C$ -1.27M | C$ -1.48M | C$ -1.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 10.24K | C$ 59.14K | C$ 1.43K | C$ 5.62K | C$ 16.06K |
| Total Assets | C$ 1.45M | C$ 225.66K | C$ 181.51K | C$ 189.14K | C$ 161.20K |
| Total Debt | C$ 4.68M | C$ 4.46M | C$ 3.89M | C$ 3.23M | C$ 2.93M |
| Net Debt | C$ 4.67M | C$ 4.40M | C$ 3.89M | C$ 3.23M | C$ 2.91M |
| Total Liabilities | C$ 7.69M | C$ 6.86M | C$ 5.96M | C$ 4.82M | C$ 4.27M |
| Stockholders' Equity | C$ -6.24M | C$ -6.64M | C$ -5.78M | C$ -4.64M | C$ -4.10M |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.72M | C$ -428.49K | C$ -296.97K | C$ -222.64K | C$ -481.59K |
| Operating Cash Flow | C$ -1.72M | C$ -426.69K | C$ -296.97K | C$ -222.64K | C$ -426.39K |
| Investing Cash Flow | C$ -2.96K | C$ -1.80K | C$ 0.00 | C$ 850.00 | C$ -52.70K |
| Financing Cash Flow | C$ 1.68M | C$ 487.64K | C$ 293.62K | C$ 211.72K | C$ 136.75K |
Currency in CAD
